包含源自口蹄疫病毒（FMDV）两个独立抗原位点序列的嵌合脊髓灰质炎病毒可在豚鼠体内诱导产生针对FMDV的中和抗体。
Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.
作者信息
Kitson J D, Burke K L, Pullen L A, Belsham G J, Almond J W
机构信息
AFRC Institute for Animal Health, Pirbright Laboratory, Woking, United Kingdom.
出版信息
J Virol. 1991 Jun;65(6):3068-75. doi: 10.1128/JVI.65.6.3068-3075.1991.
Abstract
Five poliovirus recombinants containing sequences corresponding to foot-and-mouth disease virus (FMDV) antigenic sites were constructed. Viable virus was recovered from four of these plasmids, in which the VP1 beta B-beta C loop (antigenic site 1) of poliovirus type 1 Sabin had been replaced with sequences derived from the VP1 beta G-beta H loop (antigenic site 1) of FMDV O1 Kaufbeuren (O1K), chimera O1.1 (residues 141 to 154), chimera O1.2 (residues 147 to 156), and chimera O1.3 (residues 140 to 160) or from the beta B-beta C loop of VP1 (antigenic site 3) in chimera O3.1 (residues 40 to 49). One chimera (O1.3) was neutralized by FMDV-specific polyclonal serum and monoclonal antibodies directed against antigenic site 1 of FMDV. Chimeras O1.3 and O3.1 induced site-specific FMDV-neutralizing antibodies in guinea pigs. Chimera O1.3 was capable of inducing a protective response against FMDV challenge in some guinea pigs.
摘要
构建了5种含有与口蹄疫病毒（FMDV）抗原位点相对应序列的脊髓灰质炎病毒重组体。从其中4种质粒中回收了活病毒，其中1型脊髓灰质炎病毒Sabin株的VP1 βB-βC环（抗原位点1）已被源自FMDV O1 Kaufbeuren（O1K）、嵌合体O1.1（第141至154位氨基酸）、嵌合体O1.2（第147至156位氨基酸）和嵌合体O1.3（第140至160位氨基酸）的VP1 βG-βH环（抗原位点1）的序列所取代，或者被嵌合体O3.1（第40至49位氨基酸）中VP1的βB-βC环（抗原位点3）所取代。一种嵌合体（O1.3）被FMDV特异性多克隆血清和针对FMDV抗原位点1的单克隆抗体所中和。嵌合体O1.3和O3.1在豚鼠中诱导了位点特异性的FMDV中和抗体。嵌合体O1.3能够在一些豚鼠中诱导针对FMDV攻击的保护性反应。
相似文献
1
Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.包含源自口蹄疫病毒（FMDV）两个独立抗原位点序列的嵌合脊髓灰质炎病毒可在豚鼠体内诱导产生针对FMDV的中和抗体。
J Virol. 1991 Jun;65(6):3068-75. doi: 10.1128/JVI.65.6.3068-3075.1991.
2
Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV.由口蹄疫病毒（FMDV）嵌合体制备的疫苗可诱导产生中和抗体，并对多种血清型的口蹄疫病毒产生保护性免疫。
J Virol. 1994 Nov;68(11):7092-8. doi: 10.1128/JVI.68.11.7092-7098.1994.
3
Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.来自天然牛宿主的抗O1血清型口蹄疫病毒单克隆抗体识别与小鼠所定义的相似抗原特征。
J Gen Virol. 1998 Jul;79 ( Pt 7):1687-97. doi: 10.1099/0022-1317-79-7-1687.
4
Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.利用单克隆抗体分析O1布吕赫口蹄疫病毒中和表位
J Gen Virol. 1986 Oct;67 ( Pt 10):2083-92. doi: 10.1099/0022-1317-67-10-2083.
5
Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus.含有口蹄疫病毒衣壳蛋白VP1 C端区域部分的TrpE融合蛋白所提供的保护作用。
J Gen Virol. 1991 Apr;72 ( Pt 4):967-71. doi: 10.1099/0022-1317-72-4-967.
6
Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants.由单克隆抗体和中和逃逸病毒变体所定义的O1型口蹄疫病毒的中和位点
Virology. 1988 Jan;162(1):21-9. doi: 10.1016/0042-6822(88)90390-x.
7
[Neutralization of foot-and-mouth disease virus O1 Campos by antibodies induced by a synthetic peptide].
Rev Argent Microbiol. 1988 Apr-Jun;20(2):69-75.
8
Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection.口蹄疫病毒在有无免疫选择情况下的不同抗原变异体库
J Virol. 1993 Oct;67(10):6071-9. doi: 10.1128/JVI.67.10.6071-6079.1993.
9
Use of substituted and tandem-repeated peptides to probe the relevance of the highly conserved RGD tripeptide in the immune response against foot-and-mouth disease virus.使用取代肽和串联重复肽探究高度保守的RGD三肽在抗口蹄疫病毒免疫反应中的相关性。
FEBS Lett. 1993 Sep 20;330(3):253-9. doi: 10.1016/0014-5793(93)80883-v.
10
Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus.O型口蹄疫病毒衣壳表面的新型抗体结合决定簇
J Gen Virol. 2014 May;95(Pt 5):1104-1116. doi: 10.1099/vir.0.060939-0. Epub 2014 Feb 28.
引用本文的文献
1
Structural prediction of chimeric immunogen candidates to elicit targeted antibodies against betacoronaviruses.嵌合免疫原候选物的结构预测，以引发针对β冠状病毒的靶向抗体。
PLoS Comput Biol. 2025 Feb 5;21(2):e1012812. doi: 10.1371/journal.pcbi.1012812. eCollection 2025 Feb.
2
Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface.通过再次接触在病毒表面表达 JC 表位的灭活口蹄疫病毒实现血清学转换。
Vaccines (Basel). 2023 Sep 14;11(9):1487. doi: 10.3390/vaccines11091487.
3
Structural prediction of chimeric immunogens to elicit targeted antibodies against betacoronaviruses.用于引发针对β冠状病毒的靶向抗体的嵌合免疫原的结构预测
bioRxiv. 2024 Sep 28:2023.01.31.526494. doi: 10.1101/2023.01.31.526494.
4
Challenges and prospects for the control of foot-and-mouth disease: an African perspective.口蹄疫防控的挑战与前景：非洲视角
Vet Med (Auckl). 2014 Oct 3;5:119-138. doi: 10.2147/VMRR.S62607. eCollection 2014.
5
Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in Mice.重组脑心肌炎病毒在小鼠体内引发针对猪繁殖与呼吸综合征病毒和猪瘟病毒的中和抗体。
PLoS One. 2015 Jun 15;10(6):e0129729. doi: 10.1371/journal.pone.0129729. eCollection 2015.
6
Identification of H-2d restricted T cell epitope of foot-and-mouth disease virus structural protein VP1.鉴定口蹄疫病毒结构蛋白 VP1 中的 H-2d 限制性 T 细胞表位。
Virol J. 2011 Sep 7;8:426. doi: 10.1186/1743-422X-8-426.
7
Foot-and-mouth disease.口蹄疫
Clin Microbiol Rev. 2004 Apr;17(2):465-93. doi: 10.1128/CMR.17.2.465-493.2004.
8
Viral vectors for veterinary vaccines.兽用疫苗的病毒载体
Adv Vet Med. 1999;41:145-61. doi: 10.1016/s0065-3519(99)80014-7.
9
Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.水疱性口炎病毒糖蛋白的口疮病毒嵌合体的免疫原性
J Virol. 1996 Dec;70(12):8492-501. doi: 10.1128/JVI.70.12.8492-8501.1996.
10
Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.从感染了表达1型人类免疫缺陷病毒（HIV-1）Gag的脊髓灰质炎病毒复制子的细胞中释放病毒样颗粒。
J Virol. 1996 Apr;70(4):2643-9. doi: 10.1128/JVI.70.4.2643-2649.1996.
本文引用的文献
1
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence.通过用根据病毒核苷酸序列预测的化学合成肽进行免疫接种来预防口蹄疫。
Nature. 1982 Jul 1;298(5869):30-3. doi: 10.1038/298030a0.
2
Chemical basis of antigenic variation in foot-and-mouth disease virus.口蹄疫病毒抗原变异的化学基础。
Nature. 1983;306(5944):694-7. doi: 10.1038/306694a0.
3
Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.针对预先选定肽段的抗体可识别并中和口蹄疫病毒。
EMBO J. 1982;1(7):869-74. doi: 10.1002/j.1460-2075.1982.tb01262.x.
4
The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.在完整的口蹄疫病毒颗粒上，通过中和单克隆抗体检测到的主要抗原决定簇在分离出的VPI中不存在。
J Gen Virol. 1983 May;64(Pt 5):1193-8. doi: 10.1099/0022-1317-64-5-1193.
5
Location and primary structure of a major antigenic site for poliovirus neutralization.脊髓灰质炎病毒中和主要抗原位点的定位及一级结构
Nature. 1983 Feb 24;301(5902):674-9. doi: 10.1038/301674a0.
6
Location and characterization of the antigenic portion of the FMDV immunizing protein.口蹄疫病毒免疫蛋白抗原部分的定位与特性分析
J Gen Virol. 1982 Apr;59(Pt 2):295-306. doi: 10.1099/0022-1317-59-2-295.
7
Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus.脊髓灰质炎病毒抗原位点中蛋白酶切割位点的体内保守性。
J Gen Virol. 1987 Jul;68 ( Pt 7):1857-65. doi: 10.1099/0022-1317-68-7-1857.
8
The atomic structure of Mengo virus at 3.0 A resolution.门戈病毒3.0埃分辨率下的原子结构。
Science. 1987 Jan 9;235(4785):182-91. doi: 10.1126/science.3026048.
9
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.用纯化的T7 RNA聚合酶合成传染性脊髓灰质炎病毒RNA
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2330-4. doi: 10.1073/pnas.83.8.2330.
10
Three-dimensional structure of poliovirus at 2.9 A resolution.分辨率为2.9埃的脊髓灰质炎病毒三维结构。
Science. 1985 Sep 27;229(4720):1358-65. doi: 10.1126/science.2994218.
Zotero 插件